Gene test may cut bleeding risk in heart attack survivors

NCT ID NCT05577988

Recruiting now Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jan 19, 2026 · Last updated May 15, 2026 · Updated 22 times

Summary

This study looks at whether a quick genetic test can help doctors pick a milder blood thinner for heart attack patients who are at high risk of bleeding. About 2,468 adults who had a heart attack and are on strong blood thinners will be randomly assigned to either continue a strong drug or switch to a gentler one based on their genes. The goal is to see if the gene-guided approach leads to fewer bleeding problems while still preventing future heart issues.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hopital Pitié Salpetrière
RECRUITING

Paris, IDF, 75013, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MYOCARDIAL INFARCTION